The Resurgence of Antibody Drug Conjugates: How ADCs are tak...
Michelle Miller, PhD, Global Senior Scientific Director, Bioanalytical Services What is an ADC? Anti...
Blog
PBMCs or Whole Blood? Strategic Applications in Phase I Stud...
Studying peripheral blood mononuclear cells (PBMCs) reveals cell-specific biomarkers—like target eng...
Blog
The Rising Tide of Weight Reduction Therapies
Sabina Paglialunga, PhD Senior Director, Scientific Affairs Weight reduction drugs are making a big...
Blog
Rethinking Drug Development: The Role of Model-Informed Appr...
By Johannes Stanta, PhD, Global Scientific Director, Celerion Inc. As drug development continues to...
Blog
Smarter, Faster, Safer: Celerion Unveils Major Upgrade to La...
At Celerion, we believe that innovation in the lab shouldn’t come at the cost of simplicity or secur...
Blog
FDA Endorses Human-Relevant Nonclinical Models: A Welcome Sh...
by Johannes Stanta, PhD – Global Scientific Director, Sabina Paglialunga, PhD – Senior Scientific Di...
Blog
Ruling the Future: How the ACLA’s LDT Court Victory and Euro...
by Chad Briscoe, Executive Vice President, Global Bioanalytical Services, Celerion Someone whom I’ve...
Blog
Reframing the Definition of Obesity
Sabina Paglialunga, PhD Senior Director, Scientific Affairs Two notable guidance documents addressin...
Blog
GLP-1 Agonist-Induced Delayed Gastric Emptying – A Clinical...
By Sabina Paglialunga, PhD & Aernout van Haarst, PhD Senior Directors Scientific Affairs Glucago...